Radnor Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.68M Buy
25,190
+629
+3% +$117K 0.75% 26
2025
Q1
$5.15M Sell
24,561
-86
-0.3% -$18K 0.86% 20
2024
Q4
$4.38M Sell
24,647
-3,268
-12% -$581K 0.73% 27
2024
Q3
$5.51M Buy
27,915
+2,561
+10% +$506K 0.82% 20
2024
Q2
$4.35M Buy
25,354
+260
+1% +$44.6K 1.33% 12
2024
Q1
$4.57M Sell
25,094
-2,591
-9% -$472K 0.78% 20
2023
Q4
$4.29M Buy
27,685
+273
+1% +$42.3K 0.8% 20
2023
Q3
$4.09M Buy
27,412
+2,017
+8% +$301K 0.81% 21
2023
Q2
$3.42M Buy
25,395
+8,829
+53% +$1.19M 1.46% 10
2023
Q1
$2.64M Buy
16,566
+1,200
+8% +$191K 0.69% 31
2022
Q4
$2.53M Sell
15,366
-707
-4% -$116K 0.62% 35
2022
Q3
$2.16M Sell
16,073
-40
-0.2% -$5.37K 0.63% 33
2022
Q2
$2.47M Buy
16,113
+469
+3% +$71.8K 0.68% 33
2022
Q1
$2.54M Buy
15,644
+433
+3% +$70.2K 0.64% 39
2021
Q4
$2.06M Buy
15,211
+3,307
+28% +$448K 0.51% 53
2021
Q3
$1.28M Buy
11,904
+450
+4% +$48.5K 0.76% 24
2021
Q2
$1.29M Buy
11,454
+150
+1% +$16.9K 0.44% 60
2021
Q1
$1.22M Buy
11,304
+300
+3% +$32.5K 0.39% 64
2020
Q4
$1.18M Buy
11,004
+535
+5% +$57.3K 0.33% 66
2020
Q3
$917K Buy
10,469
+850
+9% +$74.5K 0.31% 75
2020
Q2
$954K Buy
9,619
+1,444
+18% +$143K 0.34% 67
2020
Q1
$622K Hold
8,175
0.26% 83
2019
Q4
$724K Hold
8,175
0.22% 96
2019
Q3
$619K Hold
8,175
0.2% 104
2019
Q2
$594K Buy
8,175
+3,850
+89% +$280K 0.2% 104
2019
Q1
$349K Sell
4,325
-775
-15% -$62.5K 0.11% 138
2018
Q4
$470K Hold
5,100
0.17% 112
2018
Q3
$482K Buy
5,100
+500
+11% +$47.3K 0.15% 122
2018
Q2
$426K Hold
4,600
0.16% 124
2018
Q1
$435K Sell
4,600
-391
-8% -$37K 0.15% 140
2017
Q4
$483K Sell
4,991
-100
-2% -$9.68K 0.15% 135
2017
Q3
$369K Hold
5,091
0.12% 141
2017
Q2
$369K Sell
5,091
-870
-15% -$63.1K 0.12% 141
2017
Q1
$388K Hold
5,961
0.13% 136
2016
Q4
$373K Buy
+5,961
New +$373K 0.13% 142